Founder of Danerius LLC, Alan W. Dunton is a businessperson who has been the head of 6 different companies and currently is Senior Vice President-Research & Development at Purdue Pharmaceuticals LP.
He is also on the board of 5 other companies.
In the past Alan W. Dunton held the position of President & Chief Executive Officer for Panacos Pharmaceuticals, Inc., President, Chief Operating Officer & Director at Emisphere Technologies, Inc., Head-Research & Development at Purdue Pharma LP, Chief Medical Officer for Adhera Therapeutics, Inc., Principal at Danerius LLC, Senior Executive at Johnson & Johnson Chairman for Janssen-Cilag International NV, President & Managing Director at The Janssen Research Foundation, VP-Global Clinical Research & Development at R.W. Johnson Pharmaceutical Research Institute and Member-Group Operating Committee at Johnson & Johnson Pharmaceutical Group (which are all subsidiaries of Johnson & Johnson), Non-Executive Chairman of EpiCept Corp., President & Chief Executive Officer of Metaphore Pharmaceuticals, Inc., Chief Medical Officer at Derma Sciences, Inc., Vice President-Clinical Research & Development at Syntex Corp., Vice President-Clinical Research & Development at Ciba-Geigy Corp. and Vice President-Clinical Research & Development at Hoffmann-La Roche, Inc.
Alan W. Dunton received a doctorate from New York University School of Medicine and an undergraduate degree from State University of New York at Buffalo.
RCE Price at posting:
$1.08 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)